The Big Business Behind Weight Loss Drugs

Chronic disease, anxiety, ADHD, and even the shape of a person's face could be consequences of dysfunctional breathing. And most of us, it turns out, are doing it wrong – but it’s never too late to fix it. Sanjay sits down with journalist James Nestor to discuss the fifth anniver ...  عرض المزيد

No, you’re not petty for feeling jealous. Research shows humans experience this emotion even before they can crawl. CNN chief medical correspondent Dr. Sanjay Gupta sits down with psychologist Dr. Joli Hamilton to demystify jealousy and why the complex emotion is not only natural ...  عرض المزيد

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ...  عرض المزيد

$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big- ...  عرض المزيد

You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ...  عرض المزيد

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  عرض المزيد